Arden Trust’s Quest Diagnostics DGX Stock Holding History

Arden Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,341	Closed	-$257K	–	369
2018 Q2	$257K	Buy	+2,341	New	+$244K	0.04%	314
2016 Q3	–	Sell	-6,221	Closed	-$506K	–	369
2016 Q2	$506K	Sell	6,221 -1,404	-18%	-$107K	0.04%	364
2016 Q1	$545K	Buy	7,625 +2,079	+37%	+$139K	0.04%	354
2015 Q4	$395K	Buy	5,546 +751	+16%	+$50.5K	0.03%	411
2015 Q3	$294K	Buy	4,795 +1,027	+27%	+$71.8K	0.02%	519
2015 Q2	$274K	Buy	3,768 +367	+11%	+$27.1K	0.04%	361
2015 Q1	$261K	Buy	+3,401	New	+$244K	0.04%	366

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

Arden Trust's DGX Position: Q3 2018 in Review

Arden Trust sold out of Quest Diagnostics (DGX) in Q3 2018, closing a stake of 2,341 shares — an estimated $257K sold.

Arden Trust first reported a position in DGX in Q1 2015 and held it in 7 quarters. The position peaked at $545K in Q1 2016. 674 funds tracked by Wall St. Rank hold DGX as of Q3 2018.

Arden Trust reported no remaining Quest Diagnostics position as of Q3 2018 after selling out during the quarter.
Arden Trust sold 2,341 Quest Diagnostics shares in Q3 2018, an estimated $257K.
Arden Trust first reported a position in Quest Diagnostics in Q1 2015 and held it in 7 quarters.
Arden Trust's Quest Diagnostics position peaked at $545K in Q1 2016.
674 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2018.

Based on Arden Trust's 13F filing for Q3 2018, filed 30 Oct 2018.